Not all stem cell researchers are celebrating the Obama reversal of the Bush ban: Canada's Globe and Mail headlines a story As U.S. emerges from dark age, Canada's scientific edge fades .
"...the United States Friday became the first country in the world to approve a clinical trial of embryonic stem cells in human patients.
But in Canada's research community, Mr. Obama's plans have sparked anxiety that if this country fails to keep pace, it will have a tougher time recruiting smart people and convincing talent not to flock south. In short, Canada could lose its competitive edge to the Obama advantage."
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.